Molecular Mechanisms of Lipotoxicity in Nonalcoholic Fatty Liver Disease

被引:474
|
作者
Malhi, Harmeet [1 ]
Gores, Gregory J. [1 ]
机构
[1] Mayo Clin, Miles & Shirley Fiterman Ctr Digest Dis, Coll Med, Rochester, MN 55905 USA
关键词
Bim; c-jun N-terminal kinase; oleic acid; palmitic acid; hepatocyte injury;
D O I
10.1055/s-0028-1091980
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Nonalcoholic fatty liver disease (NAFLD) is characterized by insulin resistance, which results in elevated serum concentration of free fatty acids (FFAs). Circulating FFAs provide the substrate for triacylglycerol formation in the liver, and may also be directly cytotoxic. Hepatocyte apoptosis is a key histologic feature of NAFLD, and correlates with progressive inflammation and fibrosis. The molecular pathways leading to hepatocyte apoptosis are not fully defined; however, recent studies suggest that FFA-induced apoptosis contributes to the pathogenesis of nonalcoholic steatohepatitis. FFAs directly engage the core apoptotic machinery by activating the proapoptotic protein Bax, in a c-jun N-terminal kinase-dependent manner. FFAs also activate the lysosomal pathway of cell death and regulate death receptor gene expression. The role of ER stress and oxidative stress in the pathogenesis of nonalcoholic steatohepatitis has also been described. Understanding the molecular mediators of liver injury should promote development of mechanism-based therapeutic interventions.
引用
收藏
页码:360 / 369
页数:10
相关论文
共 50 条
  • [1] Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease
    Mota, Manoela
    Banini, Bubu A.
    Cazanave, Sophie C.
    Sanyal, Arun J.
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2016, 65 (08): : 1049 - 1061
  • [2] Molecular mechanisms of steatosis in nonalcoholic fatty liver disease
    Pettinelli, P.
    Obregon, A. M.
    Videla, L. A.
    [J]. NUTRICION HOSPITALARIA, 2011, 26 (03) : 441 - 450
  • [3] Molecular Mechanisms of Nonalcoholic Fatty Liver Disease (NAFLD)/Nonalcoholic Steatohepatitis (NASH)
    Ota, Tsuguhito
    [J]. CAROTENOIDS: BIOSYNTHETIC AND BIOFUNCTIONAL APPROACHES, 2021, 1261 : 223 - 229
  • [4] Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis
    Koo, Seung-Hoi
    [J]. CLINICAL AND MOLECULAR HEPATOLOGY, 2013, 19 (03) : 210 - 215
  • [5] Mediterranean diet and nonalcoholic fatty liver disease: molecular mechanisms of protection
    Godos, Justyna
    Federico, Alessandro
    Dallio, Marcello
    Scazzina, Francesca
    [J]. INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION, 2017, 68 (01) : 18 - 27
  • [6] Pathophysiology and Mechanisms of Nonalcoholic Fatty Liver Disease
    Haas, Joel T.
    Francque, Sven
    Staels, Bart
    [J]. ANNUAL REVIEW OF PHYSIOLOGY, VOL 78, 2016, 78 : 181 - 205
  • [7] Antioxidant Mechanisms in Nonalcoholic Fatty Liver Disease
    Liu, Wensheng
    Baker, Susan S.
    Baker, Robert D.
    Zhu, Lixin
    [J]. CURRENT DRUG TARGETS, 2015, 16 (12) : 1301 - 1314
  • [8] Mechanisms of Disease Progression in Nonalcoholic Fatty Liver Disease
    Jou, Janice
    Choi, Steve S.
    Diehl, Anna Mae
    [J]. SEMINARS IN LIVER DISEASE, 2008, 28 (04) : 370 - 379
  • [9] Mechanisms of Disease: pathogenesis of nonalcoholic fatty liver disease
    Arun J Sanyal
    [J]. Nature Clinical Practice Gastroenterology & Hepatology, 2005, 2 : 46 - 53
  • [10] Mechanisms of disease: pathogenesis of nonalcoholic fatty liver disease
    Sanyal, AJ
    [J]. NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2005, 2 (01): : 46 - 53